BARDA Awards $20.5M To Sabin Vaccine Institute To Research Marburg, Sudan Ebolavirus Vaccines

Homeland Preparedness News: BARDA awards more than $20M for Marburg, Sudan ebolavirus vaccines
“The Biomedical Advanced Research and Development Authority (BARDA) awarded the Albert B. Sabin Vaccine Institute Inc. of Washington, D.C., with about $20.5 million to develop vaccines against Marburg virus and Sudan ebolavirus infections. Both diseases are caused by the same family of viruses as the Ebola virus, which is currently affecting communities in the Democratic Republic of the Congo. … With the award, the Sabin Vaccine Institute will conduct studies and complete manufacturing activities to advance the development of both vaccines…” (Kovaleski, 10/3).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.